Randomized clinical study for BCAA and trace element-contained supplement in COPD

Randomized clinical study for BCAA and trace element-contained supplement in COPD - Randomized clinical study for BCAA-contained supplement in COPD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003358

Enrollment

Registered

2010-05-06

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

standard treatment and nutrition intervention using BCAA and trace element-contained supplement group standard treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COPD outpatient in our hospital who agree in this sutdy

Exclusion criteria

Exclusion criteria: COPD patient who has allergy in this BCAA and trace element-contained supplement

Design outcomes

Primary

Measure	Time frame
the change of pre-albumin	—

Countries

Japan

Contacts

Public ContactToshitaka Maeno

Saitama Medical School Department of Respirology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026